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Vascular endothelial dysfunction and capillary loss are currently considered to be a
primary phenotype of normal human aging and Alzheimer’s disease (AD). Activation
of protein kinase C (PKCε) improves several molecular, cellular, physiological, and
behavioral endpoints, yet it is not known whether a loss of PKCε activity occurs
in the microvascular endothelium in aged and AD hippocampi, whether this loss
contributes to microvascular change, or whether activation of PKCε protects against
microvascular damage, an early change that induces age-associated memory defect
and AD. We investigated the effect of the PKCε activation on microvascular loss in the
hippocampus, important for memory storage. In cultured human brain microvascular
endothelial cells, tert-butyl hydroperoxide induced oxidative stress and a decrease in
manganese superoxide dismutase (MnSOD) mRNA and protein expression that were
blocked by the antioxidant drugs. The PKCε activators bryostatin and DCPLA methyl
ester increased PKCε, associated with an increase in MnSOD mRNA and its protein as
well as vascular endothelial growth factor (VEGF), which was inhibited by the mRNAstabilizing HuR inhibitors. In rats (>24 months old) and AD transgenic mice Tg2576
(5 months old), bryostatin or DCP-LA prevented a decrease in vascular PKCε, MnSOD,
and VEGF and prevented microvascular loss and age-related memory impairment. An
autopsy-confirmed AD hippocampus showed a decrease in PKCε and MnSOD mRNAs
and their proteins and VEGF as well as in microvascular density compared to non-AD
controls. In conclusion, the PKCε activation can rescue a decrease in PKCε, MnSOD,
and VEGF via posttranscription regulation and alleviate oxidative stress, and in doing so,
prevent microvascular loss during aging and AD.
Keywords: aging, Alzheimer’s disease, hippocampus, PKCε, oxidative stress, microvessel
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is evident during aging (El Assar et al., 2013). Loss of PKCε
occurs in AD neurons (Hongpaisan et al., 2013; Sen et al.,
2018). Activation of PKCε improves several molecular, cellular,
physiological, and behavioral endpoints, including degradation of
Aβ, prevention of synaptic loss, induction of synaptogenesis, and
prevention of cognitive deficits and memory loss (Hongpaisan
et al., 2011; Sen et al., 2012).
It is not known whether a loss of PKCε activity also occurs
in the MV endothelium in aged and AD hippocampi, whether
this loss contributes to MV change, or whether activation of
PKCε protects against MV damage, which is one of several early
changes that induce age-associated memory defect and AD. In the
present study, we studied the effects of the PKCε activator and
peroxide tert-butyl hydroperoxide (TBHP)-induced oxidative
stress on PKCε, MnSOD, and VEGF in human brain MV
endothelial cells (HBMEC) in cultures. We also measured
changes in PKCε, MnSOD, and VEGF in microvessels associated
with MV density in the hippocampus and the therapeutic
effects of the PKCε activators 8-(2-(2-pentyl-cyclopropylmethyl)cyclopropyl)-octanoic acid (DCP-LA) and bryostatin in agerelated memory impaired rats, AD transgenic mice Tg2576,
and/or autopsy-confirmed AD human subjects. Change in
microvessels was focused in the stratum radiatum of the dorsal
hippocampal CA1 area, comprising apical dendrites of the CA1
pyramidal neurons. Changes in dendritic spine morphology
and synaptic density in the dorsal hippocampus – particularly
the generation of mushroom spines and synapses within the
apical dendrites of CA1 pyramidal neurons– are correlated with
changes in spatial memory (Hongpaisan and Alkon, 2007).

INTRODUCTION
Cerebral rarefaction of capillaries and terminal arterioles results
in reduced microcirculation and hypoxia, often attributed to
neurodegeneration and currently considered to be a primary
phenotype of normal human aging and Alzheimer’s disease (AD)
(Kemper et al., 1999; Riddle et al., 2003; Desai et al., 2009;
Arvanitakis et al., 2011; Brown and Thore, 2011; Toda, 2012;
Ungvari et al., 2018). In addition, disruption of the blood-brain
barrier (BBB) has been shown to prevent the clearance of amyloid
beta (Aβ), which is known to increase during aging and AD,
not only leading to amyloid plaque deposition, but also an
increase in oxidative stress, inflammation, and cerebrovascular
damage (Hawkes et al., 2011; Qosa et al., 2014). Moreover,
oxidative damage is considered another main driving force in
the aging process as well as in AD pathogenesis (Harman, 1956;
Nunomura et al., 2001; Sanz and Stefanatos, 2008). Therefore,
drugs targeting microvascular (MV) damage and oxidative stress
may be candidates for treating age-related memory impairment
and AD (Kaan et al., 2013).
The three prime untranslated region (30 -UTR) is the section
of messenger RNA (mRNA) that immediately follows the
translation termination codon. The 30 -UTR often contains
regulatory regions that post-transcriptionally influence gene
expression. Protein kinase C (PKC) can activate the nuclear
export and transport of the mRNA-stabilizing embryonic lethal,
abnormal vision (ELAV), Drosophila -like, or human antigen
(Hu) family proteins (HuR, HuB, HuC, and HuD) that will bind
with AU-rich (ARE) sequence in the 30 -UTR, resulting in the
inhibition of mRNA degradation (Chung et al., 1997; Antic and
Keene, 1998; Quattrone et al., 2001; Pascale et al., 2004, 2005). The
30 -UTRs of human manganese superoxide dismutase (MnSOD)
and vascular endothelial growth factor A (VEGF-A or VEGF)
have multiple ARE sequences (King, 2000; Wang et al., 2001;
Chaudhuri et al., 2012; Arcondeguy et al., 2013). HuR protein
prevents VEGF mRNA degradation that enhances VEGF protein
synthesis in vascular endothelial cells (Arcondeguy et al., 2013).
PKCε and PKCα isozymes may promote the transcription of
the mitochondrial antioxidant MnSOD in human lung cells and
acute myeloid leukemia (Chung et al., 2011; Di Marcantonio
et al., 2018). PKCε can increase expression of VEGF outside
of the brain (Amadio et al., 2012). Others have reported that
PKCε stimulates cardiovascular endothelial cell proliferation
and angiogenesis (Davis et al., 2007); protects against oxidative
damage, inflammation, and apoptosis (Chattopadhyay et al.,
2014); and supports endothelial integrity via tight junctions
(Sonobe et al., 2009).
A decrease in PKC activity has also been observed in the
aging brain at the level of the whole hippocampus (Battaini and
Pascale, 2005; Govoni et al., 2010). Down-regulation of PKCε
isozyme occurs at the neuronal cell or structural level in the
hippocampal CA1 area in aged rats (Hongpaisan et al., 2013).
Synaptic formation in the hippocampal CA1 area is important for
spatial memory retention, and synaptic loss in this hippocampus
is associated with age-related memory impairment (Hongpaisan
and Alkon, 2007; Hongpaisan et al., 2013). Additionally, downregulation of MnSOD, parallel to elevation of oxidative stress,
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MATERIALS AND METHODS
Cell Culturing
Human brain MV endothelial cells (Neuromics, Edina, MN,
United States, cat # HEC02 or ScienCell Research Laboratories,
Carlsbad, CA, United States, cat # 1000) at subculture
passage 2–5 were grown on fibronectin-coated cover glasses
(0.8 mm diameter) in 12-well plates or fibronectin-coated 6-well
plates. Cultured cells were maintained in endothelial medium
(ScienCell) supplemented with the endothelial cell growth
supplement (ECGS, ScienCell) and 5% fecal calf serum up to
3 days at about 1 ml per well (3.5 cm2 surface area) on the 12-well
plate or 3 ml per well (9.6 cm2 surface area) on the 6-well plate.
Because unlike most other cell types, HBMEC could not survive
under serum-free medium to induce maturity, the limited culture
medium and fecal calf serum, without fresh culture medium
change, allowed HBMEC cells to initially multiply and thereafter
reach maturity during the gradual exhaustion of serum. For
immunohistochemistry, cultured cells growing on cover glasses
were fixed with 4% paraformaldehyde at room temperature for
15–20 min and kept in phosphate buffered saline (PBS) at 4◦ C.

Measurement of Superoxide
The specific probe hydroethidine (Thermo Fisher Scientific,
Waltham, MA, United States, cat # D11347) was used to
measure changes in cellular superoxide (O2 •− ) production
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stored in PBS at 4◦ C. Under the stereoscope, the right brain
was dissected, and the midbrain and cortex part were removed
to expose the hippocampus. The right dorsal hippocampus
and cerebral cortex were excised. A small piece of filter paper
partially wet with PBS was used to remove excessive PBS and
to transfer tissue to mount on the vibratome stage with super
glue that was spread to a thin layer with another dried filter
paper. Using the remaining cerebral cortex as the support, the
hippocampus was sectioned with a vibratome (Leica VT1200S;
Leica Microsystems, Wetzlar, Germany) into 200 µm (for
mouse) or 300 µm (for rat) thickness and kept in series in PBC
at 4◦ C. The hippocampal cross-sections were excised from the
serial sections; #1, #4, #7, and #9 (400 µm apart for mouse or
600 µm apart for rat) were further fixed in 4% formaldehyde in
PBS at 4◦ C overnight to harden the tissue. The 200 or 300-µm
thickness tissue section was mounted on a vibratome stage
with a thin layer of super glue and then cut again with the
vibratome into 5 µm thickness by adjusting the suitable knife
angle, sectioning arm speed, and vibrating frequency. Four
hippocampal sections at 5-µm thickness were then processed
free-floating for immunohistochemistry and cytochemistry.
A watercolor painting brush #0 trimmed to have just a couple
of hairs was used to carry thin tissue sections from the buffer
bath of vibratome. Tissue sections (clear of excessive glue)
were immersed with the painting brush to attach the container
floor without rocking or shaking during antibody incubation
or washing to prevent the sections floating on the surface of
solution.

(Sen and Hongpaisan, 2018). The reaction between O2 •− and
non-fluorescent hydroethidine generates a highly specific red
fluorescent product, 2-hydroxyethidium. In biological systems,
another red fluorescent product ethidium is also formed,
usually at a much higher concentration than 2-hydroxyethidium
(Zielonka and Kalyanaraman, 2010). Cultured cells, grown on
glass slides, were incubated with hydroethidine (2 µg/ml) at
room temperature for 15–20 min and then fixed with 4%
paraformaldehyde. Increased O2 •− production was qualitatively
determined with a confocal microscope at 488 nm/>510 nm
(excitation/emission).

Aged Rats With Learning Impairment
Brown Norway rats were obtained from the National Institute
on Aging, National Institutes of Health (NIH) facilities (Harlan,
Indianapolis, IN, United States). Animals were housed in an
animal facility for 1 month prior to experiment to recover from
transport. Young rats (5 months) and aged rats (>24 months)
were trained in a water maze pool, as previously described
(Hongpaisan et al., 2013). In short, rats were trained to find
a platform hidden by dissolving non-toxic white tempera
(BesTemp; Certified Color Corp., Orange, CA, United States)
in the water (two swims per day for 5 days). Aged rats were
divided into two groups: (1) aged, learning-unimpaired group;
and (2) aged, learning-impaired group (Hongpaisan et al., 2013).
Only aged, learning-impaired rats were used in the present study.
Rats were injected with the PKCε activators (5 µg/kg bryostatin
[MilliporeSigma, Burlington, MA, United States, cat # 203811]
or 1.5 mg/kg DCP-LA [MedChemExpress, Monmouth Junction,
NJ, United States, cat # HY-108599A] diluted with normal saline,
i.p., every other day for five injections before and three more
injections during spatial memory training), compared to young
and aged rats injected with normal saline (in the absence of the
PKCε activator). Ten days after the first 5-day swim, rats were
trained for the second 5-day swim. At 24 h later, the probe test
was carried out to test the memory of rats to concentrate their
swimming on the removed platform area.

Human Brain Tissue Preparation
The pathological diagnosis of AD was conducted according to
the Consortium to Establish a Registry for Alzheimer’s Disease
(CERAD). All patients (or relatives/representatives who had
the power of attorney) signed informed consent forms. The
present work was carried out in accordance with the Code
of Ethics of the World Medical Association (Declaration of
Helsinki) for experiments involving humans1 . Autopsied brains
were fixed in 10% formalin. Human hippocampal samples at
0.4 cm thickness were processed for paraffin embedding. Paraffinembedded sections (10 µm) were mounted on glass slides
and deparaffinized with xylene (two times; 5 min each) and
100% ethanol for 5 min. Tissue sections were then rehydrated
with graded alcohol. For antigen retrieval of human autopsies,
deparaffinized hippocampal sections were incubated in 10 mM
citrate buffer pH 6.0 added with 0.05% Tween at 95◦ C for
30 min.

Alzheimer’s Disease Transgenic Mice
Male Tg2576 [Genotype: Hemizygous for 129S6.CgTg(APPSWE)2576Kha N20] and wild-type control mice
(approximately 2 months old) were purchased from Taconic
(Hudson, NY, United States) and housed for 1 week before
the experiment to recover from transport stress. Bryostatin,
kindly provided by the National Cancer Institute (NCI), NIH
(Bethesda, MD, United States), was administered in 2 doses/week
for 14 weeks (30 µg/kg body weight, dissolved in sterile normal
saline, i.p.). Non-treated groups received the same volume
of normal saline, mechanism of delivery, and frequency of
administration as the treated groups.

Immunohistochemistry, Cytochemistry,
and Confocal Microscopy
Tissue specimens were treated with Image-iTTM FX signal
enhancer (Thermo Fisher Scientific, Waltham, MA, United
States) for 30 min and PBS containing 15% serum and 0.5%
Triton X-100 for 60 min at room temperature, to block nonspecific protein binding sites. For primary antibody incubation,
specimens were incubated overnight at room temperature,

Animal Brain Tissue Preparation
Rats and mice were deeply anesthetized with sodium
pentobarbital (120 mg/kg body weight, i.p.). Animals were
perfused through the heart with cold PBS for less than 4 min to
wash out the blood and subsequently with 4% paraformaldehyde
in PBS. Brains were then removed, postfixed for 20 min, and
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except that human tissue were incubated at 4◦ C for 3 days and
at room temperature for 24 h. Primary antibodies are anti-PKCε
(rabbit polyclonal IgG; 1:100; MilliporeSigma, Burlington,
MA, United States, Cat # 06-991), platelet/endothelial cell
adhesion molecules-1 (PECAM or CD31, goat polyclonal
antibody, Santa Cruz Biotechnology, Dallas, Tx, United States,
cat # sc-37664), anti-PKCα (mouse monoclonal IgG; 1:100;
MilliporeSigma, Burlington, MA, United States/Upstate,
cat # 23336), anti-MnSOD (rabbit polyclonal IgG; 1:100;
MilliporeSigma, Burlington, MA, United States, cat # 06984), and anti-VEGF (mouse monoclonal IgG; 1:50; Santa
Cruz Biotechnology, Dallas, Tx, United States, cat # sc-7269).
Specimens were then incubated with biotinylated horse antimouse antibody (1:20; Vector Laboratories, Burlingame, CA,
United States, cat # BA-2000) and/or Alexa Fluor 568 donkey
anti-rabbit (cat # A10042) or goat (cat # A11057) antibody
(1:200; Thermo Fisher Scientific, Waltham, MA, United States)
for 3 h at room temperature. For blood vessel staining, rodent
tissue sections were incubated with biotin-conjugated isolectin
B4 (IB4) from Bandeiraea simplicifolia (Griffonia simplicifolia,
1:50; Vector Laboratories, Burlingame, CA, United States, cat #
B-1205) at room temperature for 4 h. Tissue sections treated with
biotinylated antibody or lectin were incubated with Alexa Fluor
488 streptavidin (1:100; Thermo Fisher Scientific, Waltham, MA,
United States, cat # S11223A) for 3 h at room temperature. After
each lectin and/or antibody incubation, the samples were washed
with PBS three times (each time for a period of 5 min). Sections
were mounted with VECTASHIELD mounting medium with
DAPI (Vector Laboratories, Burlingame, CA, United States) to
counterstain nuclei. For negative controls, primary or secondary
antibodies was were replaced with protein with no antigenicity
against the tested antibody.
Hippocampal slices were oriented with a Zeiss Axio Observer
Z1 microscope equipped with a 710 confocal scanning system
using the 10x objective lens in the DAPI channel (for staining
nuclei). The random CA1 area that appeared immediately after
switching to the higher magnification lens, either 63X or 100x
Plan-APO Chromat oil immersion objectives (1.4 NA), was
imaged for appropriate fluorescence (e.g., Alexa 488 and/or 568).
Confocal images of hippocampal sections were acquired in line
scan mode with a pinhole of approximately 1.00 Airy unit and
averaged data from several images were reported.

one of the 225 possible integers from 0 to 255 to each pixel.
Individual cells were identified with specific immune-expression
(Alexa 488 or 568) to stain the target proteins and their DAPIstained nucleus. The border of each individual cultured cell
was rather clear, while the border between two adjacent cells
in the in situ microvessels was imagined at the middle line
between 2 different nuclei. Under ImageJ program, regions of
interest (ROI) of each individual cell were manually drawn
and analyzed for the mean gray intensity value from the pixels
of:
1. Alexa 488 or 568 within the cell area (the cytosol
and nucleus together) for target protein, except for
mitochondrial MnSOD (only in the cytoplasm), and
2. DAPI within the nuclear area.
Data were collected at a single cell level (Alexa 488 or 568
intensity of the target protein normalized with its nuclear DAPI
intensity). Data were averaged from the overall cells collected
under the same experiment group. The averaged control data
were set at 100%, and all other experiment data were defined as %
of their controls.

Cell Lysis and Western Blot Analysis
Cultured cells were harvested in homogenizing buffer
(HB) containing 10 mM Tris-Cl (pH 7.4), 1 mM PMSF
(phenylmethylsulfonylfluoride), 1 mM EGTA, 1 mM EDTA,
50 mM NaF, 20 µM leupeptin, and 1% Triton X-100 and
were lysed by sonication. Protein concentration was measured
using the Coomassie Plus (Bradford) Protein Assay kit (Pierce,
Rockford, IL, United States). About 20 µg of protein from
each sample was subjected to SDS-PAGE analysis in a 4–
20% gradient Tris-glycine polyacrylamide gel (Invitrogen,
Waltham, MA, United States). The separated protein was
then transferred to a nitrocellulose membrane, blocked
with BSA, and incubated at 4◦ C overnight with primary
antibodies: anti-PKCε (rabbit polyclonal IgG; 1:500; Novus
Biologicals, Littleton, CO, United States, NBP2-19848), antiMnSOD (mouse monoclonal IgG; 1:1,000; MilliporeSigma,
Burlington, MA, United States, cat # 06-984), anti-VEGF
(rabbit polyclonal IgG; 1:500; Invitrogen, Waltham, MA, United
States, cat # PA1-16948), anti- β -Actin (mouse monoclonal
IgG; 1:25,000, Millipore, MABT825 or rabbit polyclonal IgG;
1:25,000, Novus Biologicals, Littleton, CO, United States,
NBP2-7636). After being washed three times with TBS-T
(Tris-buffered saline-Tween 20), the membrane was further
incubated with alkaline phosphatase conjugated secondary
antibody (1:10,000) for 45 min. The membrane was again
washed three times with TBS-T and developed with the 1-step
NBT-BCIP substrate (Pierce, Rockford, IL, United States).
The blot was imaged in an ImageQuant RT-ECL (GE Life
Sciences, Piscataway, NJ, United States), and densitometric
quantification was performed using Image J software. For
quantifying expression of a protein, the densitometric value
for the protein of interest was normalized against β-Actin
(loading control).

Quantitative Analysis of
Immunohistochemistry
Protein expression was determined with semi-quantitative
analysis. All tissue samples within the same experiment were
processed for immunohistochemistry at the same time and
imaged with the same set-up of confocal microscope (the same
objective lens, digital magnification, etc.) within the same day.
At least five images were randomly collected from each culture,
animal, and human brain. The confocal images were transferred
to quantify them in another computer with the ImageJ program2 .
The individual image was collected at 1024 pixels × 1024 pixels.
For individual analysis, a group of eight bits was assigned
2
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RNA Isolation and Quantitative PCR
Human brain MV endothelial cells cultured cells from 6well or p100 plates were washed with 1X PBS followed by
trypsinization using diluted trypsin added to each well at
room temperature. Cells were observed under a microscope for
complete dissociation and transferred to 1.5-ml Eppendorf tubes
containing fetal bovine serum and mixed to inactivate trypsin
spin at 1000 rpm for 5 min. The supernatants were removed,
pellets were washed with 1 ml 1X PBS, 350 µl RLT buffer was
added, and the cells were stored at –80 for subsequent RNA
isolation. Total RNA was isolated using RNeasy kit with on
column DNase treatment following the manufacturer’s protocol.
The 1 µg of total RNA was reverse transcribed (RT) using
Omniscript (Qiagen, Germantown, MD, United States), and
quantitative real-time PCR (qPCR) was performed with FAST
SYBR Green or Fast TaqMan master mix (Life Technologies,
Carlsbad, CA, United States) on the Step One plus ABI 7000
machine (Applied Biosystems, Waltham, MA, United States).
Data were normalized to 18S. PCR assays are:

Assay name

Assay ID

Vendor

PKC epsilon (PRKCE)

HP208540

Origene

MnSOD

Hs00167309_m1

Thermofisher

B-Actin

Hs99999903_m1

Thermofisher

18S

Hs99999901_s1

Thermofisher

VEGFA

Hs00900055_m1

Thermofisher

FIGURE 1 | The PKCε activator prevents an increase in reactive oxygen
species (ROS) and a decrease in MnSOD mRNA expression and increases
PKCε mRNA expression in human brain microvascular endothelial cells
(HBMEC) treated with tert-butyl hydroperoxide (TBHP). (A) TBHP was used to
induce mitochondrial dysfunction and an increase in reactive oxygen species
(ROS), including superoxide (O2 •− ). Cultured cells were treated with 0, 50,
200, or 500 µM TBHP for 1 h and recovered in new culture medium without
TBHP for 1 or 3 days. The reaction between O2 •− and non-fluorescent
hydroethidine generates highly specific red fluorescent products, ethidium and
2-hydroxyethidium (Zielonka and Kalyanaraman, 2010) were used to
determine (B) concentration-dependent effect of TBHP on intracellular O2 •−
production. (C–F) Cells had been incubated with 500 µM TBHP for 1 h and
were incubated in fresh culture medium without TBHP in an absence or
presence of the PKCε activator bryostatin (bry, 25 nM) or DCPLA-ME (DCP,
100 nM) for 3 days. (C) Effects of bryostatin and DCPLA-ME on O2 •−
production, determined by ethidium and 2-hydroxyethidium as in the panel
(A). Quantitative PCR (qPCR) was used to determine (D) PKCε, (E) MnSOD,
and (F) VEGF mRNA expression. Data are represented as mean ± SEM,
*p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA and post hoc Tukey’s
multiple comparison test (n = 110–465 random cells from 3 to 4
cultures/group) or Student’s t-test for double measurement qPCR (n = 4–5
cultures/group).

Statistical Analysis
Data with two experimental groups, western blot, and qPCR
were analyzed with Student’s t-test. For experiments with three
or more groups, data with a significant overall difference among
the groups as demonstrated by ANOVA were further analyzed by
Tukey multiple comparisons. The confidence level was set at 95%
(α = 0.05).

RESULTS
Effects of the PKCε Activator on the
Tert-Butyl Hydroperoxide-Induced
Increase in Superoxide (O2 •− ) Production
Oxidative damage is the main driving force in the aging process
(Harman, 1956; Sanz and Stefanatos, 2008). Stable organic
peroxide TBHP was used to induce mitochondrial dysfunction,
leading to an increase in O2 •− and oxidative stress (Elmlinger
et al., 2011; Fedotcheva and Mokhova, 2013). Cultured HBMEC
cells at 95% confluence were treated with 50, 200, or 500 µM
TBHP for 1 h and switched to the fresh culture medium without
TBHP for 3 days, compared to control cells treated accordingly
without TBHP. Fluorescence imaging of ethidium was used to
determine O2 •− level (Figure 1A). Intracellular O2 •− level was
increased on day 3, but not day 1, in a TBHP concentrationdependent fashion (Figure 1B). TBHP only at 500 µM was then
used in later experiment.

Frontiers in Aging Neuroscience | www.frontiersin.org

After 500 µM TBHP for 1 h, cultured HBMEC cells
were treated with the PKCε activator bryostatin (25 nM,
MilliporeSigma, Burlington, MA, United States) or DCPLA-ME
(100 nM, MedChemExpress, Monmouth Junction, NJ, United
States) for 3 days, compared with control cells treated accordingly
without TBHP and the PKCε activator. As summarized in
Figure 1C, bryostatin and DCPLA-ME decreased intracellular
O2 •− level compared to the basal O2 •− level in cells without
TBHP treatment but prevented an increase in O2 •− level in cells
treated with TBHP. The results indicate that PKCε activation can
reduce oxidative stress.
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FIGURE 2 | PKCε activation increases PKCε, MnSOD, and VEGF protein expression in cultured human brain microvascular endothelial cells (HBMEC) treated with
tert-butyl hydroperoxide (TBHP). Cultured cells were treated with 500 µM TBHP for 1 h and incubated in new culture medium with or without the PKCε activators
bryostatin (bry, 25 nM) and DCPLA-ME (DCP, 100 nM) for 3 days. (A,B,E,F,I,J) Immunohistochemistry imaged with confocal microscopy and (C,D,G,H,K,L) western
blot analysis of (A–D) PKCε, (E–H) MnSOD, and (I–L) VEGF. M, molecular weight marker. Data are represented as mean ± SEM, *p < 0.05; **p < 0.01;
***p < 0.001; one-way ANOVA and post hoc Tukey’s multiple comparison test (n = 59–134 MnSOD-immunostained cells or 451–907 PKCε or VEGF-immunostained
cells from 3 to 4 cultures/group or t-test (n = 3 cultures/western blot group).

with immunohistochemistry (Figures 2A,E,I) and western
blotting (Figures 2C,G,K). TBHP decreased MnSOD mRNA
(Figure 1E) and protein (Figures 2E–H) but had no effect
on PKCε (Figures 1D, 2A–D) and VEGF (Figures 1F, 2I–
L) mRNA and protein expression. The results indicate that
TBHP-dependent oxidative stress is correlated with a decrease
in MnSOD, but not PKCε and VEGF, mRNA expression
and translation.

Effect of the PKCε Activator on the
Tert-Butyl Hydroperoxide-Induced
Change in PKCε, Manganese Superoxide
Dismutase, and Vascular Endothelial
Growth Factor
Change in mRNA expression was studied with quantitative PCR
(qPCR, Figures 1D–F), while protein expression was studied

Frontiers in Aging Neuroscience | www.frontiersin.org
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of the superoxide scavenger Nac and the superoxide dismutase
mimetic drug MnTMPyP was studied in cultured cells treated
with 500 µM TBHP for 1 h and maintained in culture medium
for 3 days. Nac and MnTMPyP inhibited the effect of TBHP on
the decrease in MnSOD protein expression, as determined with
immunohistochemistry (Figures 3A,B) and western blot analysis
(Figures 3C,D). Nac and MnTMPyP also blocked the TBHPdependent decrease in MnSOD mRNA expression (Figure 3E).
The results suggested that treatment with 500 µM TBHP for
1 h increases ROS production and oxidative stress that decreases
MnSOD mRNA expression.

Effect of the PKCε-Dependent
mRNA-Stabilizing Protein HuR on
Manganese Superoxide Dismutase and
Vascular Endothelial Growth Factor
Expression

FIGURE 3 | Reactive oxygen species (ROS) affects MnSOD mRNA and
protein expression in cultured human brain microvascular endothelial cells
(HBMEC) treated with tert-butyl hydroperoxide (TBHP). Cultured cells were
incubated with the ROS scavenger N-acetylcysteine (Nac, 5 mM for 15 h) or
the cell-permeable SOD mimetic manganese (III)
tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP, 25 µM for 45 min) and were
then treated with TBHP at 500 µM for 1 h and recovered without TBHP, Nac,
and MnTMPyP for 3 days. (A,B) Immunohistochemistry and (C,D) western
blot analysis were used to study MnSOD protein expression. (E) Quantitative
PCR (qPCR) was used to determine MnSOD mRNA expression. Data are
reported as mean ± SEM. Asterisks over the bars (*p < 0.05; **p < 0.01;
***p < 0.001) compared with their according controls, set as 100%. Student’s
t-test for mRNA expression and western blot analysis (n = 4–5 cultures/group)
or one-way ANOVA with post hoc Tukey’s multiple comparison test for
immunohistochemistry (n = 42–160 random cells from 3 to 4 cultures per
group).

The HuR inhibitors dihydrotanshinone-I (DHTS) and CMLD2 were used to study whether PKCε activated the mRNA
stabilizing protein HuR, leading to the promotion of MnSOD
and VEGF expression (Lal et al., 2017; Allegri et al., 2019).
To investigate whether PKCε can activate HuR that can bind
and chaperone the mRNA from the nucleus to the cytoplasm,
immunohistochemistry was used to study the export of HuR
from the nucleus to the cytoplasm during the PKCε activation
(Figure 4A). Bryostatin and DCPLA-ME decreased the nuclear
HuR per cytoplasmic HuR ratio compared to the control level,
indicating that PKCε activation is associated with the nuclear
export of HuR. The nuclear export of HuR was inhibited with
the interfere of the specific binding of HuR to the ARE-binding
sites in the mRNAs by the DHTS and CMLD-2 (Figure 4A).
Protein expression was studied with immunohistochemistry
(Figures 4B,F) and western blotting, while change in mRNA
expression was studied with qPCR (Figures 4C,D,G,H). The
HuR inhibitors, DHTS and CMLD-2, significantly suppressed
the PKCε-activated increase in MnSOD protein (Figures 4B–D)
as well as mRNA expression (Figure 4E). DHTS and CMLD-2
also inhibited the PKCε-activated increase in VEGF expression
(Figures 4F–H). The results indicate that posttranscription effect
of PKCε on the increase in MnSOD and VEGF expression.

In cells without TBHP treatment, the PKCε activator
DCPLA-ME did not affect PKCε, MnSOD, and VEGF mRNA
expression (Figures 1D–F) but increased their protein
translation (Figures 2B,D,F,J). In cells treated with TBHP,
DCPLA-ME prevented the TBHP-induced decrease in MnSOD
mRNA expression (Figure 1E). When compared with controls,
bryostatin or DCPLA-ME in cells treated with TBHP did not
increase PKCε, MnSOD, and VEGF mRNAs (Figures 1D–F)
but increased their protein expression (Figures 2B,D,F,H,J,L).
The results suggest that PKCε activation may promote PKCε,
MnSOD, and VEGF protein expression without the increase in
their mRNA expression.

Effect of the PKCε Activator in Rat
Hippocampus With Age-Related Memory
Impairment

Effect of the Reactive Oxygen Species
Scavengers on the Tert-Butyl
Hydroperoxide-Induced Decrease in
Manganese Superoxide Dismutase
mRNA and Protein Expression

Rats were trained with water maze swim learning for 5 days.
For learning acquisition, aged (24 months old) rats with learning
impairment exhibited increased swimming (latency) time to
reach the hidden platform compared to young (5 months old)
adult rats (Figure 5A). Age-related learning impairment was
improved by bryostatin or DCPLA-ME treatment starting on day
3 of swim learning (Figure 5A). At 24 h after the final training
swim, all animals underwent a probe test to evaluate whether they
remembered the location of the platform despite being removed
from the test area (Figure 5B). Age-related memory-impaired
rats had poor memory to swim across to the removed platform

To verify whether the oxidative damage affect MnSOD mRNA
and protein expression, cultured cells were incubated with the
reactive oxygen species (ROS) scavenger N-acetylcysteine (Nac)
or the cell-permeable SOD mimetic manganese (III) tetrakis(1methyl-4-pyridyl)porphyrin (MnTMPyP) (Sen et al., 2018). Effect
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FIGURE 4 | The mRNA-stabilizing protein HuR involved in PKCε-activated MnSOD and VEGF expression in human brain microvascular endothelial cells (HBMEC).
HBMEC cells were treated with the HuR inhibitor CMLD-2 (35 µM) or dihydrotanshinone-I (DHTS, 10 µM) for 30 min before and during the 3-day incubation in the
presence of the PKCε activator bryostatin (25 nM) or DCPLA-ME (100 nM). (A) Immunohistochemistry of HuR was used to study nuclear export of the HuR protein.
(B) Immunohistochemistry and (C,D) western blot analysis of MnSOD protein expression. (E) Quantitative PCR (qPCR) of MnSOD mRNA expression. (F)
Immunohistochemistry and (G,H) western blot analysis of VEGF protein expression. M, molecular weight marker. Data are represented as mean ± SEM, *p < 0.05;
***p < 0.001; one-way ANOVA and post hoc Tukey’s multiple comparison test (n = 59–134 MnSOD-immunostained cells or 451–907 PKCε or VEGF-immunostained
cells from 3 to 4 cultures/group or t-test (n = 3 cultures/western blot group).

endothelial cells (Laitinen, 1987; Benton et al., 2008), bound with
biotin/avidin/green fluorescence dye complex (Figures 5C,E,
6A). PKCε, MnSOD, and VEGF were decreased in the MV
endothelium in age-related memory-impaired rats compared to
control young rats (Figures 5D,F, 6B). Bryostatin abolished
the aging-dependent reduction in PKCε to the young control
level (Figure 5D). For the effect related to oxidative stress,
bryostatin treatment also rescued the aging-dependent decreases
in MnSOD and even increased MnSOD higher than the level
in young rats (Figure 5F). For the effect on angiogenesis, the
reduction of VEGF in aged rats was reversed with bryostatin

site in the water maze compared to young rats (Figure 5B).
Bryostatin and DCP-LA increased spatial memory to the young
control level (Figure 5B).
We studied MV density in the hippocampal CA1 stratum
radiatum using the isolectin B4 (IB4), which specifically binds
terminal α-galactosyl residues of vascular endothelial cells to
stain MV endothelium (Laitinen, 1987; Benton et al., 2008).
Confocal microscopy was used to quantify immunostained levels
of PKCε, MnSOD, and VEGF; each of them was colocalized
with the vascular endothelial the isolectin B4 (IB4), which
specifically binds terminal α-galactosyl residues of vascular
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FIGURE 6 | The PKCε activator prevents a decrease in vascular VEGF and
MV loss in the CA1 hippocampal stratum radiatum from age-related memory
impairment rats. Tissue sections from rats in Figure 5 were used to stained
with cytochemistry of the vascular endothelial cell marker IB4. (A)
Colocalization of histochemistry of the vascular endothelium marker IB4 and
(B) immunohistochemistry VEGF levels. (C) Low magnification of confocal
microscope of the vascular endothelium marker IB4 was used to determine
(D). MV density in random hippocampal CA1 areas. Data are presented as
mean ± SEM; **p < 0.01, ***p < 0.001; one-way ANOVA and post hoc
Tukey’s multiple comparison test (n = 63–95 random MV cells or 32–119
random areas from 3 to 5 rats/group).

FIGURE 5 | The PKCε activator prevents spatial memory impairment and a
decrease in vascular PKCε and MnSOD in the CA1 hippocampal stratum
radiatum from aged rats. Age-related learning impairment rats (>24 months
old) were injected with the PKCε activator bryostatin (bry, 5 µg/kg body
weight) or DCP-LA (DCP, 1.5 mg/kg) diluted with normal saline, i.p., every
other day for five injections before and three more injections during spatial
memory training, compared to young (5 months old) and aged rats injected
with normal saline (in the absence of the PKCε activator). Rats were trained
with water maze to learn to find underwater platform for 5 days (2 swims/day).
At 24 h thereafter, memory was determined how rats concentrated on the
target area of the removed platform. (A) learning acquisition and (B) memory
retention in aged rats, compared to control young rats. The learning and
memory defect and MV loss were improved with the PKCε activator bryostatin
and DCP-LA. (C,E) Colocalization of histochemistry of the vascular
endothelium marker IB4 and immunohistochemistry was used to determine
(D) PKCε and (F) MnSOD. Data are presented as mean ± SEM; *p < 0.05;
**p < 0.01, ***p < 0.001; one-way ANOVA and post hoc Tukey’s multiple
comparison test (n = 7–15 rats for behavioral study [2 swims/day/rat and 1
probe test/rat] or 63–95 random MV cells or 32–119 random areas from 3 to
5 rats/group).

memory impairment. The PKCε activators bryostatin and DCPLA increase MnSOD and VEGF levels and MV density in aged
rats with memory impairment.

PKCε, Manganese Superoxide
Dismutase, and Vascular Endothelial
Growth Factor mRNA and Protein Levels
and Microvascular Density in Human
Autopsy-Confirmed Alzheimer’s Disease
Hippocampus
Autopsy-confirmed AD brains were collected between 6.83 and
28 h post-mortem (Table 1). No significant difference between
post-mortem interval and immunohistochemistry (each primary
antibody) was seen using linear regression analysis (not shown),
suggesting that our results were not affected by post-mortem
change within 28 h. The age was 79.4 ± 9.9 (mean ± S.E)
years for AD brains, compared to 78.7 ± 11.4 years for age
and gender-matched control (AC) brains. The Braak staging was
4.3 ± 0.4 (range = II–VI) for AD brains, compared to 1.4 ± 0.2
(range = 0–III) for AC brains.
Changes in PKCε, MnSOD, and VEGF were studied in AD
subjects (n = 11) and AC controls (n = 11). AC control data
were set at 100%, and all other experiment data were defined
as% of their AC controls. qPCR was used to determine change in
mRNAs at the whole hippocampal level. The PKCε and MnSOD

treatment (Figure 6B). We studied MV density using the
IB4 at low magnification confocal microscopy. Change in
MV density was determined with quantification of the IB4
area within hippocampal CA1 stratum radiatum (Figure 6C).
Blood vessels decreased in age-associated memory-impaired rats
(Figure 6D). The MV loss was rescued in the hippocampus
by bryostatin and DCP-LA compared to aged rats without
bryostatin or DCP-LA (Figure 6D). The results suggest that
the decrease in PKCε, MnSOD, and VEGF expression in MV
endothelium is associated with the MV loss during age-related
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TABLE 1 | Demographic data of human brains.
Diagnosis
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
Control
AD
AD
AD
AD
AD
AD
AD
AD
AD
AD
AD
AD
AD

Braak

Age (year)

Gender

PMI (h)

0
I
I
I
I
I
I
II
II
II
III
II
II/III
II/III
III/IV
IV
IV
V
V
V
V
V
V
VI

61
69
73
75
76
81
82
84
86
97
89
72
80
71
83
88
98
61
68
73
81
82
80
87

F
M
M
F
M
F
F
F
M
M
F
M
M
M
F
F
M
F
M
F
F
F
M
M

16.80
18.43
20.88
20.08
12.25
26.18
15.70
19.25
25.28
17.00
14.12
6.83
23.17
28
5.9
16.67
22.70
21.42
15.67
17.67
20.75
18
15
15.25

FIGURE 8 | Reduction of VEGF protein, but not mRNA, expression and
microvascular loss in the CA1 stratum radiatum of autopsy-confirmed AD
human hippocampus. (A) Quantitative PCR (qPCR) was used to detect VEGF
mRNA at the whole hippocampus level. (B,C) Immunohistochemistry and
confocal microscopy were used to determine VEGF protein expression in MV
wall cells in hippocampal CA1 area (N, the nucleus of MV wall cell). (D,E)
Immunofluorescence of the vascular endothelial cell marker CD31/PECAM
was used to determine MV density. AC, age-matched control; AD,
autopsy-confirmed Alzheimer’s disease. Although VEGF mRNA was not
different among the experiment groups, VEGF and MV density was decreased
in AD hippocampi at the early Braak stages II–III, but not AD at the late Braak
stages IV–VI, compared to AC group. Data are reported as mean ± SEM,
*p < 0.05; **p < 0.01; two-tailed t-test compared with their according
controls (n = 11 hippocampi per group for qPCR or n = 182–365 random MV
cells from 11 hippocampi per group, or 87–105 random CA1 areas from 5 AD
Braak II–III, 14 AD Braak IV–VI and 19 AC).

MV endothelium in the hippocampal CA1 stratum radiatum
(Figures 7B,E). In parallel to changes in mRNA expression at the
whole hippocampal level, MV endothelium in the hippocampus
showed a decrease in PKCε and mitochondrial MnSOD levels
(Figures 7C,F). The results indicate that AD pathogenesis is
involved in the damage of PKCε and MnSOD mRNA expression,
resulting in a decrease in PKCε and MnSOD translation.
Although VEGF mRNA was not changed in AD hippocampi
(Figure 8A), VEGF protein expression in the MV wall cells
was reduced in the AD hippocampi at Braak stages II-III, but
not AD stages IV-VI, compared to the AC controls (Braak
stages 0-III, Figures 8B,C). This suggests that AD pathogenesis
is associated with decreased VEGF synthesis and/or increased
VEGF degradation. Using immunohistochemistry of the vascular
endothelial marker PECAM-1/CD31, overall MV area density
was determined as % of MV fraction in random areas of the
hippocampal CA1 radiatum (Figure 8D). The MV area in the AD
hippocampi was decreased at Braak stages II-III, but not Braak
stages IV-VI (Figure 8E). The results indicate that a decrease in
PKCε, MnSOD and VEGF expression and the loss of microvessels
is associated with AD pathogenesis.

FIGURE 7 | Reduction of PKCε and mitochondrial MnSOD mRNA and protein
expression in the CA1 stratum radiatum of autopsy-confirmed AD human
hippocampus. (A,D) Quantitative PCR (qPCR) was used to detect PKCε
mRNA at the whole hippocampus level and (B,C,E,F) immunohistochemistry
and confocal microscopy were used to determine protein expression in MV
wall cells in hippocampal CA1 area (N, the nucleus of MV wall cell). (A) mRNA
and (B,C) protein expression for PKCε. (D) mRNA and (E,F) protein
expression for MnSOD. AC, age-matched control; AD, autopsy-confirmed
Alzheimer’s disease. PKCε and MnSOD mRNA and protein expression were
reduced in overall AD brains (Braak stages II–VI), compared to AC controls
(Braak stages 0–III). Data are reported as mean ± SEM, ∗ p < 0.05;
∗∗ p < 0.01; ∗∗∗ p < 0.001; two-tailed t-test compared with their according
controls (n = 11 hippocampi per group for qPCR or n = 182–365 random MV
cells from 11 hippocampi per group).

mRNAs were reduced in the AD hippocampus compared to the
AC control (Figures 7A,D). Immunohistochemistry and confocal
microscopy were used to determined protein changes in the
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FIGURE 10 | The PKCε activator protects a reduction of VEGF in MV
endothelial cells and MV density in the hippocampal CA1 area from Tg2576
transgenic AD mice. Tissue sections from animals in Figure 9 were used. (A)
Double immunohistochemistry and confocal microscopy of (B) VEGF in
vascular endothelial cells that were marked with PECAM/CD31. (C)
Cytochemistry of the vascular endothelial cells marker IB4, imaged with a
confocal microscope, was used to determine (D) MV density in random CA1
areas. Bryostatin (bry) prevented the loss of VEGF and MV density in Tg2576
(Tg) mice. Data are represented as mean ± SEM, **p < 0.01; one-way
ANOVA and post hoc Tukey’s multiple comparison test. (n = 35–74 random
MV cells or 19–28 random areas from 3 to 5 mice/group).

FIGURE 9 | The PKCε activator protects a reduction of PKCε and MnSOD in
the hippocampal CA1 area from Tg2576 transgenic AD mice. Mice at
2 months of age were injected (i.p., twice a week) with normal saline in the
presence or absence of bryostatin (30 µg/kg body weight) for a 3-month
period. Mice were then studied at the age of 5–6 months old when an
increase in soluble amyloid-beta (Aβ) and memory defect were seen in the
hippocampus of Tg2576 mice (Hongpaisan et al., 2011). Bryostatin was
withdrawn for 2 weeks to avoid the acute effect of bryostatin. Double
immunohistochemistry and confocal microscopy of (A,B) PKCε, (A,C) PKCα,
and (D,E) MnSOD in vascular endothelial cells that were marked with
PECAM/CD31. Bryostatin (bry) prevented the loss of PKCε and MnSOD and
promoted PKCα in Tg2576 (Tg) mice. Data are represented as mean ± SEM,
*p < 0.05; ***p < 0.001; one-way ANOVA and post hoc Tukey’s multiple
comparison test. (n = 35–74 random MV cells from 3 to 5 mice/group).

Although PKCα concentration was not changed in Tg2576 mice,
bryostatin significantly increased PKCα (Figures 9A,C). MnSOD
was decreased in MV endothelial cells in Tg2576 mice compared
to wild-type controls (Figures 9D,E). Treatment with bryostatin
prevented the decrease in MnSOD (Figures 9D,E).
We further determined change of VEGF level. Compared
to wild-type littermate sibling mice, a reduction of VEGF
in MV endothelial cells in Tg2576 mice was prevented after
bryostatin treatment (Figures 10A,B). IB4 histochemistry was
used to determine MV density (Figure 10C). The PKCε activator
bryostatin prevented the MV loss in Tg2576 mice (Figure 10D).
Taken together, the results suggest that the PKCε activator can
prevent the decrease in PKCε MnSOD and VEGF levels and in
MV loss in AD transgenic mice Tg2576.

Effect of the PKCε Activator on Vascular
Manganese Superoxide Dismutase and
Vascular Endothelial Growth Factor in
the Hippocampi of Alzheimer’s Disease
Transgenic Mice Tg2576
Function effect of PKCε was studied in animal models treated
with the PKCε activator drug, bryostatin. The effect of PKCε
on MV density, VEGF, and MnSOD was studied in Tg2576
transgenic AD mice that overexpress a mutant form of APP
(isoform 695) with the Swedish mutation (KM670/671NL).
Double immunohistochemistry and confocal microscopy were
used to evaluate PKCε, PKCα, MnSOD, and VEGF levels in
vascular endothelial cells marked with platelet endothelial cell
adhesion molecule (PECAM-1) or cluster of differentiation 31
(CD31) (Figures 9A,D, 10A).
Because bryostatin is a potent activator of PKCε and to a
lesser extent PKCα (Hongpaisan and Alkon, 2007), changes in
PKCε and PKCα were determined. Compared to the wild-type
control mice, PKCε level in Tg2576 mice was decreased in MV
endothelial cells that were treated with bryostatin (Figures 9A,B).
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DISCUSSION
The present study demonstrated that the TBHP-induced shortterm oxidative stress decreased MnSOD—but not PKCε and
VEGF—mRNA and protein expression in cultured HBMEC
cells that were blocked by superoxide degrading drugs, Nac
and MnTMPyP. The PKCε can increase PKCε mRNA and its
protein expression and increase MnSOD mRNA, MnSOD, and
VEGF expression, promoted by the mRNA-stabilizing protein
HuR that bind ARE sequence in MnSOD and VEGF mRNAs.
Under chronic conditions in animal models, reduced PKCε was
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of phospho-Akt and subsequently lead to the accumulation
of the dephosphorylated and active forkhead box O3s
(FOXO3a), which activates MnSOD mRNA transcription,
while PKCα may phosphorylate the CREB transcription
of MnSOD mRNAs (Chung et al., 2011). Binding of
VEGF on vascular endothelial growth factor receptor 2
(VEGFR2) can activate the PKC/extracellular signal-regulated
kinase (ERK) 1/2 signal cascade. In the present study, the
PKCε activator may therefore promote VEGF signaling by
directly activating extracellular signal-regulated kinase (ERK)
1/2 and vascular proliferation (Rask-Madsen and King,
2008).

associated with a decrease in MnSOD and VEGF expression in
MV endothelial cells and MV density in the hippocampi of aged
rats (>24 months old) and young AD transgenic mice Tg2576
(5–6 months old). The PKCε activators DCP-LA and bryostatin
rescued the reduction of PKCε, MnSOD, and VEGF in MV cells
and the MV loss.
During the aging process, the activity of sirtuin1 (SIRT1) in
the nucleus is reduced, which decreases the von Hippel-Lindau
(pVHL) protein levels and subsequently stabilizes hypoxiainducible factor-1α (HIF-1α). Activated HIF-1α reduces the
proliferator-activated receptor-gamma coactivator 1β (PGC-1β)
activity, resulting in the downregulation of mitochondrial genes
and MnSOD (Lu et al., 2010; Yeo, 2019). c-Myc activity is also
inhibited upon its interaction with HIF-1α. c-Myc targets generegulating processes required for cell growth, including rRNA
transcription and processing, ribosomal protein transcription
and translation, and translation initiation (Lu et al., 2010). The
reduction of c-Myc activity may elicit the loss of VEGF (Baudino
et al., 2002; Florea et al., 2013). In the present study, it is likely
that the PKCε activator may have increased SIRT1 and c-Myc,
resulting in the increase in MnSOD mRNA transcription during
oxidative stress (Li et al., 1996; Thompson et al., 2013).
In the present study, normal aging and AD pathogenesis
were associated with a decrease in PKCε, MnSOD, and VEGF,
possibly due to a prolonged and significant increase in O2 •−
that favors reaction with the free radical nitric oxide (NO· ) to
form peroxynitrite (ONO2 − ), a powerful oxidant that damages
DNA, RNA, and proteins, including PKC (Maher, 2001). On the
other hand, the PKCε activator can restore the mitochondria
antioxidant MnSOD that may buffer oxidative stress and may
inhibit the oxidative damage of PKCε and VEGF. It has
been previously shown that the PKCε activators can increase
PKCε itself; however, the mechanism is not clearly understood
(Hongpaisan et al., 2011, 2013).
In a previous study, we showed that DCP-LA and/or
bryostatin improved recent memory retention, which is
important for daily living activity, by restoring the reduction of
PKCε accumulation in axonal and presynaptic axonal boutons
and improving synaptic formation/modification in aged rats
and AD transgenic mice Tg2576 and 5xFAD. This was done
by preventing/improving PKCε-activated mRNA-stabilizing
protein HuD or ELAV-like protein 4, which inhibits mRNA
degradation and promotes MnSOD and BDNF in hippocampal
neurons (Hongpaisan et al., 2011, 2013; Sen et al., 2018). PKCε
is critical in synaptogenesis and memory (Prekeris et al., 1998;
Aranda-Abreu et al., 1999; Hama et al., 2004), and the present
study demonstrated that DCPLA and bryostatin can rescue the
loss of blood vessels by preventing and/or restoring the loss of
PKCε, MnSOD, and VEGF that may contribute to improved
learning acquisition and memory retention in animal models of
normal aging (as shown in the present study) and AD transgenic
mice Tg2576 and 5xFAD (Hongpaisan et al., 2011, 2013; for
review see Govoni et al. (2010), Talman et al. (2016)).
In the present study, the mRNA-stabilizing protein HuR is
involved in the effect of PKCε activator by suppressing MnSOD
and VEGF mRNA degradation. PKCε may stimulate protein
phosphatase 2A (PP2A) to facilitate the dephosphorylation
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CONCLUSION
During aging and AD pathogenesis, PKCε, MnSOD, and VEGF
expression decreases in MV endothelial cells and MV loss occurs
in the hippocampus. The PKCε activators can reduce the decrease
of PKCε and MnSOD mRNA and protein expression in MV cells.
PKCε activators can also increase VEGF, which is important for
angiogenesis and blood vessel maintenance.
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